Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 157.50
+1.00 (0.64%)
Oct 28, 2026, 2:00 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 110.29 billion as of October 28, 2026. It is the 4,225th most valuable company in the world and the 121st biggest in Taiwan. Its market cap has increased by 352.69% in one year.
Market Cap
110.29B
Enterprise Value
110.10B
Revenue
n/a
Global Rank
Country Rank
#121 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 110.29B, an increase of 3,682.03%. That is a compound annual growth rate of 56.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 129.77B | 295.14% |
| Dec 31, 2025 | 32.84B | 203.76% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 105.30B |
| Pell Bio-Med Technology | 52.02B |
| Oneness Biotech | 22.85B |
| Sunmax Biotechnology | 22.28B |
| CHO Pharma | 22.04B |
| TaiMed Biologics | 16.67B |
| Medigen Vaccine Biologics | 16.24B |
| Ever Supreme Bio Technology | 15.16B |